Wispostatin-3

General Information


DRACP ID  DRACP05014

Peptide Name   Wispostatin-3

Sequence  TKWTPCSRTCGMGISNRV

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Homo sapiens (WISP-3)

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C82H137N27O25S3

Absent amino acids  ADEFHLQY

Common amino acids  T

Mass  230073

Pl  9.91

Basic residues  3

Acidic residues  0

Hydrophobic residues  3

Net charge  3

Boman Index  -3846

Hydrophobicity  -43.33

Aliphatic Index  37.78

Half Life 
  Mammalian: 7.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5625

Absorbance 280nm  330.88

Polar residues  10

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18780781

Title  A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells

Doi 10.1073/pnas.0803241105

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.